3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
39
Stomach Neoplasms
29
Rectal Neoplasms
21
Pancreatic Neoplasms
19
Colonic Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
14
Esophageal Neoplasms
13
Adenocarcinoma Of Esophagus
12
Carcinoma, Non-Small-Cell Lung
11
Neoplasms
9
Neoplasm Metastasis
9
Adenocarcinoma
9
Cholangiocarcinoma
8
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Ovarian Neoplasms
6
Biliary Tract Neoplasms
6
Esophageal Squamous Cell Carcinoma
4
Endometrial Neoplasms
4
Carcinoma, Hepatocellular
4
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Gallbladder Neoplasms
3
Carcinoma
3
Bile Duct Neoplasms
3
Advanced Solid Tumors
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Interventions
Imatinib Mesylate
6
Sunitinib
4
ripretinib
2
regorafenib
2
Specimen Handling
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
IDRX-42
2
trastuzumab deruxtecan
1
pemigatinib
1
olverembatinib
1
envafolimab
1
atezolizumab
1
apatinib
1
Temozolomide
1
Surgical Instruments
1
Sorafenib
1
Rogaratinib
1
Nivolumab
1
Midazolam
1
Laparoscopy
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Biopsy
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
Oxaliplatin
×
90 days
×
Clear all
No trials found.